The medical world is seeing a major shift in blood sugar treatment with the emergence of GLP-1 skin applications. These devices offer a seemingly more user-friendly alternative to injections of GLP-1 receptor agonists, reducing the requirement of daily needle pokes. The innovation releases the compound directly through the surface, arguably boostin